Context Therapeutics to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Apr 1, 2025
PHILADELPHIA, April 01, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its participation in several upcoming investor conferences:
Read more at globenewswire.com
